124 related articles for article (PubMed ID: 15073251)
1. Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
Grigsby PW; Siegel BA; Bekker S; Clutter WE; Moley JF
J Nucl Med; 2004 Apr; 45(4):567-70. PubMed ID: 15073251
[TBL] [Abstract][Full Text] [Related]
2. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Serhal DI; Nasrallah MP; Arafah BM
J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
[TBL] [Abstract][Full Text] [Related]
3. Timing of Hormone Withdrawal in Children Undergoing 131I Whole-Body Scans for Thyroid Cancer.
Turpin S; Lambert R; Deal C
Horm Res Paediatr; 2016; 86(6):410-415. PubMed ID: 27902975
[TBL] [Abstract][Full Text] [Related]
4. Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing.
Guimaraes V; DeGroot LJ
Thyroid; 1996 Apr; 6(2):69-73. PubMed ID: 8733874
[TBL] [Abstract][Full Text] [Related]
5. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
Robbins RJ; Larson SM; Sinha N; Shaha A; Divgi C; Pentlow KS; Ghossein R; Tuttle RM
J Nucl Med; 2002 Nov; 43(11):1482-8. PubMed ID: 12411552
[TBL] [Abstract][Full Text] [Related]
6. Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
McLaughlin CM; Hunter SJ; Bell PM; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2008 Jul; 69(1):169-70. PubMed ID: 18042175
[No Abstract] [Full Text] [Related]
7. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
8. Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma.
Sánchez R; Espinosa-de-los-Monteros AL; Mendoza V; Brea E; Hernández I; Sosa E; Mercado M
Arch Med Res; 2002; 33(5):478-81. PubMed ID: 12459319
[TBL] [Abstract][Full Text] [Related]
9. [Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication].
Hackländer S; Voth E; Schicha H
Nuklearmedizin; 1996 Oct; 35(5):170-4. PubMed ID: 9005413
[TBL] [Abstract][Full Text] [Related]
10. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
[TBL] [Abstract][Full Text] [Related]
11. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
Moser E; Fritsch S; Braun S
Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
[TBL] [Abstract][Full Text] [Related]
13. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
[TBL] [Abstract][Full Text] [Related]
14. Thyroid morphology and function after surgical treatment of thyroid diseases.
Mann B; Schmale P; Stremmel W
Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
[TBL] [Abstract][Full Text] [Related]
15. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A; Claudio Traino A; Boni G; Grosso M; Lazzeri P; Colato C; Davì MV; Francia G; Lazzeri M; Mariani G; Ferdeghini M
Nucl Med Commun; 2007 Mar; 28(3):215-23. PubMed ID: 17264781
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
17. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
Shimon I; Cohen O; Lubetsky A; Olchovsky D
Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.
Robbins RJ; Tuttle RM; Sonenberg M; Shaha A; Sharaf R; Robbins H; Fleisher M; Larson SM
Thyroid; 2001 Sep; 11(9):865-9. PubMed ID: 11575856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]